we expect the company to post healthy Revenues/EBITDA/APAT growth of 12%/11%/11%CAGR respectively over FY23-25E. However,the recent appreciation in stock price leaves us with little upside and we maintain our HOLD rating on the stock with a TP of Rs 500/share, implying an upside of 2% from the CMP.